Advanced B Cell Malignancies
1 clinical trials · Condition
◉ Watch Advanced B Cell Malignancies
| Record | Firm | Date |
|---|---|---|
| A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies (NCT01957579) | AstraZeneca | 2011-05-25 |
Track Advanced B Cell Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.